No guideline or regulation promulgated under subsection (a) or (c) may require a research entity to disclose publicly trade secrets or commercial or financial information which is privileged or confidential.
42 U.S. Code § 289d - Animals in research
Pub. L. 102–394, title II, § 213, Oct. 6, 1992, 106 Stat. 1812, provided that:
Similar provisions were contained in the following prior appropriation acts:
Pub. L. 102–170, title II, § 213, Nov. 26, 1991, 105 Stat. 1127.
Pub. L. 101–517, title II, § 211, Nov. 5, 1990, 104 Stat. 2209.
Pub. L. 101–166, title II, § 214, Nov. 21, 1989, 103 Stat. 1178.
Section 4 of Pub. L. 99–158 directed Director of National Institutes of Health to establish, not later than Oct. 1, 1986, a plan for research into methods of biomedical research and experimentation which reduces the use of animals in research or which produce less pain and distress in animals to develop methods found to be valid and reliable, to train scientists in use of such methods, to disseminate information on such methods and to establish an Interagency Coordinating Committee to assist in development of the plan, prior to repeal by Pub. L. 103–43, title II, § 205(b), June 10, 1993, 107 Stat. 148. See section 283e of this title.